Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2003
10/16/2003WO2001034635A3 Methods and compositions for peptide synthesis
10/16/2003US20030196218 Improving existing lines of plants and development of new lines having desired traits by making a specific alteration of a specific pre-existing gene of a plant
10/16/2003US20030196214 Isolating mRNA from plant growing both under normal and drought conditions, reverse transcripting mRNAs to cDNA, transferring genes into plants; genes obtained from cell differentiation in different conditions
10/16/2003US20030196212 An isolated nucleic acid sequence encoding a polypeptide specific bind to the receptor; treating infertility, contraception disorders, sexual dysfunction, nervous system disorders, psychiatric disorders, liver disorders
10/16/2003US20030195349 H. pylori flbA polypeptides, immunogenic and vaccinating compositions comprising H. pylori flbA polypeptides, and compositions for detection of an infection comprising H. pylori flbA polypeptides
10/16/2003US20030195348 CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection
10/16/2003US20030195347 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195346 An isolated amino acid sequences are expressed by a cell; for use as human secreted proteins such as human insulin, interferon, Factor VIII, human growth hormones
10/16/2003US20030195345 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195344 A DNA libraries having the vector sequences for coding the membrane receptor proteins, or fusion proteins, for binding the membrane-bound proteins; drug delivery target to specific cell site
10/16/2003US20030195339 A protein is modified with a polyalkylene glycol, granulocyte colony-stimulating factor etherified with a polyoxyethylene glycol; improve protease enzyme resistance; treating patient having reduced granulocytes or thrombocytes
10/16/2003US20030195338 Concatameric immunoadhesion
10/16/2003US20030195337 UL16 binding protein 4
10/16/2003US20030195336 Nucleic acid and polypeptide compositions encoding lepidopteran-toxic polypeptides
10/16/2003US20030195335 Novel proteins and nucleic acids encoding same
10/16/2003US20030195334 Cell culturing and expressing the protein, chimeric polypeptides, fusion proteins; membrane protein receptor is used to bind the protein drugs thrombolytic agents, interferons, interleukins, erythropoietins
10/16/2003US20030195333 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195332 PNA monomer and precursor
10/16/2003US20030195227 Retroviral protease inhibitors
10/16/2003US20030195163 Fibronectins; drug screening; treating cardiovascular/nervous system disorders
10/16/2003US20030195158 Peptide derivatives
10/16/2003US20030195157 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
10/16/2003US20030195156 Tumor necrosis factors; cytokines; immunoglobulins; autoimmune diseases
10/16/2003US20030195155 Therapeutic use of the SMR1 protein, the SMR1 maturation products, specifically the QHNPR pentapeptide as well as its biologically active derivatives
10/16/2003US20030195154 Comprises mimetics of erythropoietin, thrombopoietin, and glucagon-like peptide conjugated to polymer
10/16/2003US20030195151 Glucanases; xylanases; endoxylanases; isolated from barley/oats; immunoaffinity chromatography
10/16/2003US20030195150 Antimicrobial peptides
10/16/2003US20030195149 Endozepine-like proteins, polynucleotides encoding them and methods of using the same
10/16/2003US20030195148 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030195147 Identification of molecular structures, especially peptides, which are capable of acting at either insulin or insulin-like growth factor receptors as agonists or antagonists; treatment of diabetes
10/16/2003US20030194800 For immunization, generation of packaging cell lines, and production of immunogenic compositions
10/16/2003US20030194794 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194793 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194792 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194791 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194783 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
10/16/2003US20030194782 Methods for recombinant peptide production
10/16/2003US20030194781 Used for drugs, diagnostics, biosensors and bioreactors
10/16/2003US20030194780 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194779 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194778 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194777 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194776 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194775 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194774 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194773 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194772 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194771 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194770 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194769 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194768 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194767 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194766 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/16/2003US20030194765 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194764 Compositions and methods for the therapy and diagnosis of lung cancer
10/16/2003US20030194763 End selection in directed evolution
10/16/2003US20030194761 Novel nucleic acid sequences encoding human fibroblast growth factor-like polypeptides
10/16/2003US20030194760 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194757 Specific synthetic peptide sequences used in place of partially purified proteins, infected cells or cell lysates
10/16/2003US20030194756 Peptides for detection of antibody to Ehrlichia equi
10/16/2003US20030194754 Method for the diagnosis and prognosis of malignant diseases
10/16/2003US20030194751 Method for identifying modulators of ion channels
10/16/2003US20030194749 Wortmannin derivatives as probes of cellular proteins and processes
10/16/2003US20030194747 Convergent combinatory peptide libraries and their use for vaccination against hepatitis c virus
10/16/2003US20030194744 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/16/2003US20030194743 Binding polypeptides for B lymphocyte stimulator protein (BLyS)
10/16/2003US20030194742 Diagnosis of tauopathies
10/16/2003US20030194739 Using cancer specific genes
10/16/2003US20030194737 Use of parapox B2L protein to modify immune responses to administered antigens
10/16/2003US20030194732 For treating neoplastic diseases by testing responsiveness to interferons
10/16/2003US20030194729 Conantokins
10/16/2003US20030194728 Description of genetic variants of the Solute Carrier Family 26, Member 2 (SLC26A2) gene
10/16/2003US20030194727 Screening nucleic acids that encode different artificial, chimeric proteins to identify a chimeric protein that alters a phenotypic trait of a cell or organism
10/16/2003US20030194721 Differentially expressed when foam cells are treated with oxidized low-density lipoprotein and LPS as associated with atherosclerosis
10/16/2003US20030194720 Human ion channels
10/16/2003US20030194712 Screening for target polypeptides that bind to RNA, using affinity purification methods, use of such target polypeptide for drug discovery and in methods of treating and preventing disease
10/16/2003US20030194708 Human secreted crossveinless-homolog polypeptide
10/16/2003US20030194702 Sequences for use in diagnosis and treatment of carcinomas, used in screening methods
10/16/2003US20030194695 Nucleic acid and polypeptide sequences useful as adjuvants
10/16/2003US20030194694 Pure recombinant influenza virus comprising a mutant ion channel protein which lacks or has reduced activity relative to the wild-type
10/16/2003US20030194414 Replikin peptides and antibodies therefore
10/16/2003US20030194411 Peptide compositions for the treatment and prevention of HIV infection
10/16/2003US20030194410 Vectors and host cells; chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides
10/16/2003US20030194408 Antibody which specifically binds to at least two variants of an epitope of an HIV-1 Tat protein
10/16/2003US20030194402 Methods of sustained treatment of fistulas in crohn's disease with chimeric anti-TNF antibodies
10/16/2003US20030194400 Targeted thrombosis
10/16/2003US20030194399 Preparation of deallergenized proteins and permuteins
10/16/2003US20030194398 Having serine protease inhibitory activity
10/16/2003US20030194393 Toxoplasma gondii proteins, nucleic acid molecules, and uses thereof
10/16/2003US20030194391 Vaccine
10/16/2003CA2779639A1 Multivalent constructs for therapeutic and diagnostic applications
10/16/2003CA2509767A1 Novel antagonists of mcp proteins
10/16/2003CA2483769A1 Identification and characterization of an anthocyanin mutant (ant1) in tomato
10/16/2003CA2482138A1 La1 - the genome of a lactobacillus strain
10/16/2003CA2481979A1 Peptides chemically modified with polyethylene glycol
10/16/2003CA2481764A1 Plants with improved morphogenesis and method of constructing the same
10/16/2003CA2481719A1 Modified cea nucleic acid and expression vectors
10/16/2003CA2481656A1 Cells in which activity of the protein involved in transportation of gdp-fucose is reduced or lost
10/16/2003CA2481502A1 Hcv antiviral and cytotoxicity drug screening assay
10/16/2003CA2481437A1 Motif-grafted hybrid polypeptides and uses thereof
1 ... 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 ... 2916